Key result
Intravenous or direct injection of serotonin into the pulmonary circulation results in an increase in pulmonary vascular resistance caused by vasoconstriction.
The text reviews historical evidence regarding the role of serotonin in causing bronchoconstriction and pulmonary hypertension following pulmonary embolism.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for serotonergic pathways in acute pulmonary embolism; prospective validation required before any clinical consideration.
IN 1952 Comroe1implicated serotonin as a possible source of some of the vascular sequelae following pulmonary embolism. He suggested, more specifically,2that as blood coagulates serotonin is released from the platelets and directly causes bronchoconstriction and pulmonary hypertension. He stated that bradycardia, hypotension, and apnea seem to occur on a reflex basis but attributable to serotonin. Subsequently, various investigators have reached conflicting conclusions. It is well documented that the intravenous injection or direct injection of serotonin into the pulmonary circulation results in an increase in pulmonary vascular resistance.1-18Most investigators have stated that this rise in pulmonary vascular resistance is caused by vasoconstriction. Vasoconstriction has been observed to occur in the main pulmonary artery,19the vessels between the pulmonary artery and arterioles,4and in the veins.13Knisely et al20have obtained evidence by the direct observation of pulmonary vessels that "temporary" embolization
No takes yet. Share an insight, caveat, or question.
Pat O. Daily (1966) conducted a review in Pulmonary Embolism. Serotonin was evaluated. Intravenous or direct injection of serotonin into the pulmonary circulation results in an increase in pulmonary vascular resistance caused by vasoconstriction.
Synapse has enriched 10 related papers. Consider them for comparative context: